Actions of Aviject 45,5 mg/2 ml in details
Description: Aviject 45,5 mg/2 ml is an alkylamine derivative with histamine H1-receptor antagonist effects. It also has anticholinergic and moderate sedative effects.
Onset: 15-20 min (oral).
Pharmacokinetics:
Absorption: Readily absorbed from the GI tract. Peak plasma concentrations in 1-2.5 hr.
Metabolism: Metabolised to N-desmethylpheniramine and N-didesmethylpheniramine.
Excretion: Via urine (as unchanged drug and metabolites). Terminal half-life: 8-17 hr (IV Aviject 45,5 mg/2 ml maleate); 16-19 hr (oral).
Aviject 45,5 mg/2 ml administration
Should be taken with food. Take after meals.
Aviject 45,5 mg/2 ml pharmacology
Aviject 45,5 mg/2 ml is an antihistamine used to treat allergic conditions such as hay fever or urticaria. It is generally sold in combination with other medications, rather than as a stand-alone drug. Allergies are caused by an excessive type 1 hypersensitivity response of the body to allergens, mediated by inappropriate histamine signalling. By inhibiting the binding of histamine, antihistamines decrease the normal histamine response from cells, consequently decreasing allergic symptoms.
References
- EPA DSStox. "Pheniramine: DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.". https://comptox.epa.gov/dashboard/ds... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Aviject 45,5 mg/2 ml are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Aviject 45,5 mg/2 ml. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported administration
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
